GLPHubglpresearchhub.com
Read-only archive. GLP Research Hub is a static community record — nothing here is for sale, no account is needed, and no vote you cast is counted. Why?
Single comment threadYou are looking at one branch of small win: satiety stopped being a problem at week 30 — 21 comments in the full submission. View in context.
685
c/cagrilintide·submitted 8 months ago by u/nadia_fonseca

small win: satiety stopped being a problem at week 30

Discussionbranch of 10 comments

Confession thread, sort of. I went from 2.5mg to 1.0mg much faster than I should have because the scale had stalled and I got impatient. The stall broke about 5 weeks later, at which point I had no way of knowing whether the dose increase did anything or whether it would have broken anyway. So now I have sulphur…

Read the full submission and all 21 comments →

This branch

10 comments, started 8 months ago
u/ilias_kaufmann69 points·8 months ago

This is correct. The co-agonism is real.

replysharereportpermalink
u/nadia_fonsecaOP55 points·8 months ago

long-acting amylin is co-agonism, different satiety profile

replysharereportpermalink
u/ahmed_fonseca38 points·8 months ago

research use only, no human protocols in posts

replysharereportpermalink
u/lipid_panel_larrybloodwork32 points·8 months ago

REDEFINE which arm?

replysharereportpermalink
u/sulphur_burps_sue80 points·8 months ago

research use only, no human protocols in posts

replysharereportpermalink
u/mateusz_adebayo24 points·8 months ago

tendon and cagrilintide literature in rodents is interesting

replysharereportpermalink
u/wrong_network_w57 points·8 months ago

REDEFINE phase 8 readouts are interesting but 8 person CagriSema is different from 8 trial CagriSema.

replysharereportpermalink
u/egfr_watcher56 points·8 months ago·edited

Slight fix: the number was 97.6, not 96.2. Decimal point, but a fairly consequential one.

replysharereportpermalink
u/rafael_krastev33 points·8 months ago·edited

That is net peptide content, not purity. Different number, different meaning.

replysharereportpermalink
u/runa_grimaldi20 points·8 months ago

the mechanism is different, the side effect profile reflects it

replysharereportpermalink

← back to the whole thread

About c/cagrilintide

Amylin analog pharmacology and the CagriSema combination: why amylin and GLP-1 co-agonism produces a different satiety profile, the REDEFINE readouts, and the very limited pool of people handling cagrilintide as research material.

19kmembers
62submissions
Feb 2024created
submissions / month, last year
Sponsored

Janoshik Analytical

Independent HPLC and mass spec. The number you get is the number they found.

janoshik.comSponsored

GL Biochem (Shanghai)

Custom peptides and amino acids direct from the manufacturer since 1998. ISO 9001 / cGMP. Batch COA every order.

glbiochem.net
More in c/cagrilintide
c/cagrilintide rules
  1. Amylin is not a GLP-1. Posts conflating them get corrected.
  2. CagriSema ratios in trials are fixed-dose. Do not extrapolate to self-mixing.
  3. Not approved anywhere. Keep posts descriptive, not instructional.
  4. Independent community. Nobody here sells anything, and anyone who tries is banned.
  5. Not medical advice. Describe what you did; never prescribe to a stranger.
  6. Claims need evidence. Batch numbers, dated screenshots, independent test reports, or a citation.
  7. No referral links, discount codes or affiliate URLs. Permanent ban, no appeal.
  8. No contact handles, wallet addresses or tracking numbers — they identify people.
  9. Be recognisably decent. Disagree hard, insult nobody.
Full rules and how they are enforced →
Moderators
u/amylin_amyu/incretin_ivyu/ledger_mod
Volunteers. Unpaid, unaffiliated, and reachable through modmail only.
Before you read on

Several compounds discussed on GLP Research Hub are sold for research use only and are not approved for human use anywhere. Nothing here is medical advice and none of it is written by your clinician. If a post reads like an instruction, treat it as a description of what one stranger did.

Full disclaimer →